Healthcare Sector

LQDA

Market Tracker

$14.03
-0.47
(-3.24%)
1:40 am
Next Earnings: (est.) 11/06/21 12:00 am
  • LQDA (Selected)

    Liquidia Corporation

LQDA Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

LQDA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

LQDA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

LQDA Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

LQDA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

LQDA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/20/2025 PUT $5.00 1,106 +100 +9.94%
03/21/2025 PUT $15.00 1,687 +44 +2.68%
01/16/2026 CALL $17.50 516 +40 +8.40%
03/21/2025 CALL $15.00 5,389 +12 +0.22%
07/18/2025 CALL $17.50 413 +9 +2.23%
07/18/2025 CALL $10.00 470 +5 +1.08%
10/17/2025 PUT $25.00 0 0
10/17/2025 PUT $30.00 0 0
06/20/2025 CALL $15.00 5,863 -5 -0.09%
04/17/2025 CALL $15.00 1,540 -10 -0.65%
01/16/2026 CALL $10.00 1,713 -25 -1.44%
01/16/2026 CALL $12.50 1,088 -25 -2.25%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

LQDA Major Holders

Name Pct Held Shares Total
SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF 2.76% 1.79M 13.78M
Vanguard Total Stock Market Index Fund 2.37% 1.53M 11.81M
iShares Russell 2000 ETF 1.63% 1.06M 8.14M
Vanguard Extended Market Index Fund 1.06% 683.23k 5.27M
Fidelity Small Cap Index Fund 0.61% 393.73k 3.04M
Invesco ETF Tr II-Invesco DWA Small Cap Momentum ETF 0.42% 273.91k 2.11M
Fidelity Extended Market Index Fund 0.39% 253.96k 1.96M
iShares Russell 2000 Growth ETF 0.35% 227.62k 1.75M
Russell Inv Co- Tax-Managed U.S. Mid & Small Cap Fund 0.28% 178.93k 1.38M
iShares Russell 2000 Value ETF 0.26% 169.92k 1.31M

LQDA News

  • Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

    03/12 08:00 am

    GlobeNewswire Inc.

    Read more
  • Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

    02/24 08:00 am

    GlobeNewswire Inc.

    Read more
  • Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight

    01/14 02:00 pm

    GlobeNewswire Inc.

    Read more
  • United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

    10/07 10:00 am

    GlobeNewswire Inc.

    Read more
  • Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

    10/02 06:00 am

    GlobeNewswire Inc.

    Read more
  • U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    08/19 06:00 am

    GlobeNewswire Inc.

    Read more
  • Liquidia corp chief medical officer sells $18.4k in stock - Investing.com

    07/15 09:39 pm

    Investing.com

    Read more
  • Liquidia Corp executive sells shares worth over $19,000 - Investing.com

    07/15 06:47 pm

    Investing.com

    Read more
  • Liquidia Corp executive sells over $14k in company stock - Investing.com

    07/15 06:47 pm

    Investing.com

    Read more
  • Voip-pal director Kevin Williams sells shares worth $19,234 By Investing.com - Investing.com

    07/15 06:47 pm

    Investing.com

    Read more
  • Forecasting The Future: 5 Analyst Projections For Liquidia

    06/25 03:00 pm

    Benzinga

    Read more
  • Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)

    06/18 08:42 am

    GlobeNewswire Inc.

    Read more
  • 7 Analysts Have This To Say About Liquidia

    06/03 08:00 am

    Benzinga

    Read more
  • Liquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

    05/15 08:01 am

    Benzinga

    Read more
  • MannKind Outperforms As Tyvaso DPI Captures Market Share

    05/15 01:22 am

    Seeking Alpha

    Read more
  • Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA)

    05/14 09:35 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

    05/13 05:43 pm

    GlobeNewswire Inc.

    Read more
  • Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates

    05/10 08:50 am

    Zacks Investment Research

    Read more
  • Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

    05/10 08:00 am

    GlobeNewswire Inc.

    Read more
  • Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates

    05/07 08:15 am

    Zacks Investment Research

    Read more
  • Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know

    04/26 10:00 am

    Zacks Investment Research

    Read more
  • Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline

    04/25 10:02 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

    04/02 09:00 am

    GlobeNewswire Inc.

    Read more
  • The Analyst Landscape: 5 Takes On Liquidia

    04/01 02:00 pm

    Benzinga

    Read more
  • Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    03/27 01:06 pm

    Benzinga

    Read more
  • Unveiling 6 Analyst Insights On Liquidia

    03/13 05:00 pm

    Benzinga

    Read more
  • Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates

    03/13 07:10 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

    03/13 06:00 am

    GlobeNewswire Inc.

    Read more
  • Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates

    03/07 06:10 pm

    Zacks Investment Research

    Read more
  • Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline

    03/07 11:00 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

    03/06 07:30 am

    GlobeNewswire Inc.

    Read more
  • Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates

    02/29 09:40 am

    Zacks Investment Research

    Read more
  • Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates

    02/27 09:30 am

    Zacks Investment Research

    Read more
  • Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4

    02/22 06:15 pm

    Zacks Investment Research

    Read more
  • United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates

    02/22 01:22 pm

    Zacks Investment Research

    Read more
  • Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?

    02/19 06:54 am

    Zacks Investment Research

    Read more
  • This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate

    02/12 12:00 pm

    Benzinga

    Read more
  • Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress

    01/30 07:30 am

    GlobeNewswire Inc.

    Read more
  • Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 71.41%: Read This Before Placing a Bet

    01/29 10:55 am

    Zacks Investment Research

    Read more
  • Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder

    01/25 07:00 am

    GlobeNewswire Inc.

    Read more
  • Liquidia Corporation Announces Updates to Operations Leadership

    01/19 07:30 am

    GlobeNewswire Inc.

    Read more
  • Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    01/17 02:12 pm

    Benzinga

    Read more
  • Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade

    01/09 07:21 pm

    Zacks Investment Research

    Read more
  • What Makes Liquidia Technologies, Inc. (LQDA) a Strong Momentum Stock: Buy Now?

    01/09 05:56 pm

    Zacks Investment Research

    Read more
  • Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims

    01/08 09:22 am

    GlobeNewswire Inc.

    Read more
  • Decoding 5 Analyst Evaluations For Liquidia

    01/05 09:00 am

    Benzinga

    Read more
  • Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD

    01/05 07:45 am

    GlobeNewswire Inc.

    Read more
  • Liquidia Corporation Announces $100 Million in New Financings

    01/04 10:10 am

    GlobeNewswire Inc.

    Read more
  • Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

    01/02 07:45 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: